FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3155032272> ?p ?o ?g. }

• W3155032272 endingPage "3066" @default.
• W3155032272 startingPage "3057" @default.
• W3155032272 abstract "Background: Approximately 20% resectable non-small cell lung cancer (NSCLC) patients are treated non-surgically due to various reasons. The aim of the present study was to compare the effectiveness of radiofrequency ablation (RFA) and stereotactic body radiotherapy (SBRT) in patients with stage IA NSCLC who were ineligible for surgery using the surveillance, epidemiology and end-results (SEER) Database. Methods: Using the SEER registry, we identified a total of 6,195 IA NSCLC patients who received SBRT or RFA between 2004 and 2015 because of ineligibility for surgical resection due to various reasons. Complete clinical information was available in all these patients. Overall survival (OS) and cancer-specific survival (CSS) were compared between RFA and SBRT groups by using propensity score matching (PSM), inverse probability of treatment weight (IPTW), and overlap weighting analysis. Additionally, an exploratory analysis was conducted to determine the effectiveness of RFA treatment based on the subsets of clinically relevant patients. Results: Of the 6,195 nonsurgical IA NSCLC patients, 191 patients (3.1%) received RFA and the other 6,004 patients (96.9%) received SBRT. The one-, three- and five-year OS in the unmatched RFA and SBRT groups were 83.3%, 48.5%and 29.1% vs. 83.8%, 48.3% and 27.4%, respectively, there was similar results in the PSM, IPTW, overlap weighing analysis. Nonsurgical IA NSCLC patients receiving RFA seemed to have better five-year survival than those receiving SBRT, though the difference was not statistically significant (OS, HR; 0.986; 95% CI, 0.827-1.175, P=0.8738; CSS, HR; 0.965; 95% CI, 0.765-1.219, P=0.7663). We found that the odds of receiving RFA decreased with larger tumor size (>2, 3 cm, OR; 0.153; 95% CI, 0.093-0.251) compared with tumor size <1 cm. In subgroup analysis, patients receiving RFA seemed to have better OS than those receiving SBRT, though the difference was not statistically significant. This specific trend was even more obvious in patients with tumors <1cm in diameter (P=0.1577). Conclusion: In comparison with SBRT, RFA did not seem to adversely affect CSS and OS of IA NSCLC patients who were not suitable for surgical treatment. In addition, RFA seemed to offer better survival to IA NSCLC patients, especially those with tumors <1 cm." @default.
• W3155032272 created "2021-04-26" @default.
• W3155032272 creator A5015289492 @default.
• W3155032272 creator A5021384155 @default.
• W3155032272 creator A5029360035 @default.
• W3155032272 creator A5029498134 @default.
• W3155032272 creator A5036139505 @default.
• W3155032272 creator A5042323521 @default.
• W3155032272 creator A5089192059 @default.
• W3155032272 date "2021-01-01" @default.
• W3155032272 modified "2023-10-12" @default.
• W3155032272 title "Radiofrequency ablation<i> vs.</i> stereotactic body radiotherapy for stage IA non-small cell lung cancer in nonsurgical patients" @default.
• W3155032272 cites W1529103757 @default.
• W3155032272 cites W1972491414 @default.
• W3155032272 cites W1975615190 @default.
• W3155032272 cites W1991625282 @default.
• W3155032272 cites W1996281320 @default.
• W3155032272 cites W2018476477 @default.
• W3155032272 cites W2030684845 @default.
• W3155032272 cites W2031835526 @default.
• W3155032272 cites W2034831804 @default.
• W3155032272 cites W2055557358 @default.
• W3155032272 cites W2082202968 @default.
• W3155032272 cites W2094426794 @default.
• W3155032272 cites W2095683811 @default.
• W3155032272 cites W2096114203 @default.
• W3155032272 cites W2122539766 @default.
• W3155032272 cites W2123626022 @default.
• W3155032272 cites W2153700824 @default.
• W3155032272 cites W2159971806 @default.
• W3155032272 cites W2167465019 @default.
• W3155032272 cites W2167926970 @default.
• W3155032272 cites W2170008003 @default.
• W3155032272 cites W2567462056 @default.
• W3155032272 cites W2606362026 @default.
• W3155032272 cites W2610797655 @default.
• W3155032272 cites W2749841856 @default.
• W3155032272 cites W2754282140 @default.
• W3155032272 cites W2767794254 @default.
• W3155032272 cites W2799516253 @default.
• W3155032272 cites W2823313185 @default.
• W3155032272 cites W2884958157 @default.
• W3155032272 cites W2888469629 @default.
• W3155032272 cites W2911188335 @default.
• W3155032272 doi "https://doi.org/10.7150/jca.51413" @default.
• W3155032272 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8040894" @default.
• W3155032272 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33854605" @default.
• W3155032272 hasPublicationYear "2021" @default.
• W3155032272 type Work @default.
• W3155032272 sameAs 3155032272 @default.
• W3155032272 citedByCount "9" @default.
• W3155032272 countsByYear W31550322722022 @default.
• W3155032272 countsByYear W31550322722023 @default.
• W3155032272 crossrefType "journal-article" @default.
• W3155032272 hasAuthorship W3155032272A5015289492 @default.
• W3155032272 hasAuthorship W3155032272A5021384155 @default.
• W3155032272 hasAuthorship W3155032272A5029360035 @default.
• W3155032272 hasAuthorship W3155032272A5029498134 @default.
• W3155032272 hasAuthorship W3155032272A5036139505 @default.
• W3155032272 hasAuthorship W3155032272A5042323521 @default.
• W3155032272 hasAuthorship W3155032272A5089192059 @default.
• W3155032272 hasBestOaLocation W31550322721 @default.
• W3155032272 hasConcept C126322002 @default.
• W3155032272 hasConcept C126838900 @default.
• W3155032272 hasConcept C143998085 @default.
• W3155032272 hasConcept C146357865 @default.
• W3155032272 hasConcept C151730666 @default.
• W3155032272 hasConcept C2776256026 @default.
• W3155032272 hasConcept C2777377203 @default.
• W3155032272 hasConcept C2777714996 @default.
• W3155032272 hasConcept C2778902805 @default.
• W3155032272 hasConcept C2780387249 @default.
• W3155032272 hasConcept C2992393070 @default.
• W3155032272 hasConcept C509974204 @default.
• W3155032272 hasConcept C71924100 @default.
• W3155032272 hasConcept C86803240 @default.
• W3155032272 hasConceptScore W3155032272C126322002 @default.
• W3155032272 hasConceptScore W3155032272C126838900 @default.
• W3155032272 hasConceptScore W3155032272C143998085 @default.
• W3155032272 hasConceptScore W3155032272C146357865 @default.
• W3155032272 hasConceptScore W3155032272C151730666 @default.
• W3155032272 hasConceptScore W3155032272C2776256026 @default.
• W3155032272 hasConceptScore W3155032272C2777377203 @default.
• W3155032272 hasConceptScore W3155032272C2777714996 @default.
• W3155032272 hasConceptScore W3155032272C2778902805 @default.
• W3155032272 hasConceptScore W3155032272C2780387249 @default.
• W3155032272 hasConceptScore W3155032272C2992393070 @default.
• W3155032272 hasConceptScore W3155032272C509974204 @default.
• W3155032272 hasConceptScore W3155032272C71924100 @default.
• W3155032272 hasConceptScore W3155032272C86803240 @default.
• W3155032272 hasIssue "10" @default.
• W3155032272 hasLocation W31550322721 @default.
• W3155032272 hasLocation W31550322722 @default.
• W3155032272 hasOpenAccess W3155032272 @default.
• W3155032272 hasPrimaryLocation W31550322721 @default.
• W3155032272 hasRelatedWork W2076005400 @default.
• W3155032272 hasRelatedWork W2118927768 @default.
• W3155032272 hasRelatedWork W2148241518 @default.

• next